Aid groups, health ministry plan to administer oral cholera vaccine to 100,000 Haitians

Working in conjunction with the Haitian Ministry of Health and the Haitian aid group GHESKIO, Boston-based Partners In Health (PIH) will begin an immunization campaign in January aimed at providing two doses of the oral cholera vaccine Shanchol "to 100,000 Haitians living in two vulnerable communities: a neighborhood in Port-au-Prince, where potable water and latrines are luxuries, and to an isolated rural village in the lower Artibonite Valley region," the Miami Herald reports.

According to the newspaper, "getting the international community to pay for the vaccine, which costs $185 per dose, remains a challenge." In addition, "those opposed to vaccinations are concerned that it will detract from public campaigns for better sanitary measures in Haiti, and from the need to promote potable water and improved sanitary conditions in a country were many people lack both," the newspaper writes, noting the government last year rejected a push for vaccinations over concerns of social unrest because of a limited supply (Charles, 10/19).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Public trust in COVID-19 vaccine science influences vaccine uptake in the US